BusinessOtonomy to Report First Quarter 2018 Financial Results and Provide Corporate UpdateBy Nasdaq OMXMay 2, 2018, 11:31 AM UTC
BusinessOtonomy Announces Positive Top-Line Results from Phase 3 Clinical Trial of OTIPRIO® in Patients with Acute Otitis ExternaBy Nasdaq OMXJan 5, 2017, 12:01 PM UTC
BusinessOtonomy Announces Positive Top-Line Results from Phase 3 Clinical Trial of OTIPRIO® in Patients with Acute Otitis ExternaBy Nasdaq OMXJan 5, 2017, 12:01 PM UTC
BusinessOtonomy to Present at the J.P. Morgan Healthcare ConferenceBy Nasdaq OMXJan 3, 2017, 12:30 PM UTC
BusinessOtonomy Successfully Completes Phase 2 Clinical Trial of OTIPRIO® in Pediatric Patients with Acute Otitis Media with Tympanostomy TubesBy Nasdaq OMXOct 4, 2016, 11:30 AM UTC
BusinessOtonomy to Present at Baird Global Healthcare ConferenceBy Nasdaq OMXSep 1, 2016, 11:30 AM UTC
BusinessOtonomy Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate UpdateBy Nasdaq OMXMar 7, 2016, 9:14 PM UTC
BusinessOtonomy Announces Publication Supporting Development of OTO-104 as Protectant Against Cisplatin-Induced Hearing LossBy Nasdaq OMXJan 26, 2016, 12:05 PM UTC
